SEATTLE GENETICS INC Intellectual Property Contracts & Agreements

13 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Development and License Agreement between Immunomedics, Inc. and Seattle Genetics, Inc. (February 10, 2017)
License Agreements
SEATTLE GENETICS INC
Biotechnology
NY
2017
Letter Agreement Regarding Royalty Between Seattle Genetics, Inc. and University of Miami (April 2016)
License Agreements
SEATTLE GENETICS INC
Biotechnology
2016
Amendment to License Agreement between Bristol-Myers Squibb Company and Seattle Genetics, Inc. (December 18, 2015)
License Agreements
SEATTLE GENETICS INC
Biotechnology
2016
Amendment No. 1 to Option and License Agreement between Sanquin Blood Supply Foundation and Seattle Genetics, Inc.
License Agreements
SEATTLE GENETICS INC
Biotechnology
2009
Option and License Agreement between Sanquin Blood Supply Foundation (CLB) and Seattle Genetics, Inc. dated July 5, 2001
License Agreements
SEATTLE GENETICS INC
Biotechnology
2009
License Agreement between Seattle Genetics, Inc. and Protein Design Labs, Inc. for CD33 Antibody Program
License Agreements
SEATTLE GENETICS INC
Biotechnology
WA
2005
Amendment No. 3 to License Agreement between Arizona Science & Technology Enterprises and Seattle Genetics, Inc.
License Agreements
SEATTLE GENETICS INC
Biotechnology
2004
Patent License Agreement between Protein Design Labs, Inc. and Seattle Genetics, Inc. dated January 9, 2004
License Agreements
SEATTLE GENETICS INC
Biotechnology
CA
2004
Non-Exclusive Patent License Agreement between Genentech, Inc. and Seattle Genetics, Inc. (Cabilly Coexpression Patents)
License Agreements
SEATTLE GENETICS INC
Biotechnology
CA
2003
License Agreement between Seattle Genetics, Inc. and Genentech, Inc. dated March 6, 2003
License Agreements
SEATTLE GENETICS INC
Biotechnology
WA
2003
License Agreement between RemeGen Co., Ltd. and Seagen Inc. for Antibody Drug Conjugate Technologies
License Agreements
SEATTLE GENETICS INC
Biotechnology
NY
2021
Amendment No. 1 to License Agreement between Cascadian Therapeutics, Inc. and Array BioPharma, Inc.
License Agreements
SEATTLE GENETICS INC
Biotechnology
2020
License Agreement between Array BioPharma Inc. and Oncothyreon Inc. for ARRY-380 Technology
License Agreements
SEATTLE GENETICS INC
Biotechnology
NY
2018